-
-
-
-
-
-
-
QIAGEN partners with NVIDIA to integrate AI into drug discovery platform
-
-
-
-
-
-
-
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
-
-
-
-
-
-
-
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
-
-
-
-
-
-
-
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
-
-
-
-
-
-
-
QIAGEN delivers solid Q4 2024 growth ahead of outlook
-
-
-
-
-
-
-
QIAGEN Announces 20-F Annual Report Filing for 2019 Results
-
-
-
-
-
-
-
Qiagen (QGEN) Tops Q1 EPS by 1c, Approves $100 million Share Repurchase
-
100,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

